Pfizer Reaches Settlement In Drug-Risk Securities Suit
Pfizer told the Second Circuit Tuesday it had reached a settlement in a securities class action over the alleged risks of two of its drugs and asked that its petition for...To view the full article, register now.
Already a subscriber? Click here to view full article